[{"id": "f2290bd732b805475ff652904ad6a94c", "cik": "1340652", "ticker": "CCXI", "name": "Rita I. Jain, M.D.", "position": "Executive Vice President, Chief Medical Officer", "year": 2021, "salary": 127547, "bonus": 0, "stockAwards": 77724, "optionAwards": 708287, "nonEquityIncentiveCompensation": 65625, "otherCompensation": 58407, "total": 1037589}, {"id": "d46f5c9f8427baa155d96f2cbe0cea8c", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer and Secretary", "year": 2021, "salary": 543403, "bonus": 0, "stockAwards": 2068318, "optionAwards": 1020944, "nonEquityIncentiveCompensation": 298872, "otherCompensation": 2762, "total": 3934299}, {"id": "7180f68bafcc5426d7772c94e4a90b36", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2021, "salary": 737401, "bonus": 0, "stockAwards": 5203730, "optionAwards": 2568826, "nonEquityIncentiveCompensation": 464563, "otherCompensation": 3564, "total": 8978084}, {"id": "b113dc9be377a31b01c3f2239c5a831e", "cik": "1340652", "ticker": "CCXI", "name": "Tausif Butt", "position": "Executive Vice President, Chief Operating Officer", "year": 2021, "salary": 488013, "bonus": 335000, "stockAwards": 0, "optionAwards": 4856797, "nonEquityIncentiveCompensation": 180000, "otherCompensation": 2334, "total": 5862144}, {"id": "6b0eda018c9b07dec167854dd21dded9", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2021, "salary": 464135, "bonus": 0, "stockAwards": 1284465, "optionAwards": 635149, "nonEquityIncentiveCompensation": 175443, "otherCompensation": 4004, "total": 2563196}, {"id": "d63ca15632ad1c90dd80849b1c5cef02", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2020, "salary": 707000, "bonus": 0, "stockAwards": 4831383, "optionAwards": 2400162, "nonEquityIncentiveCompensation": 424200, "otherCompensation": 3564, "total": 8366309}, {"id": "3aa351747a44d177a7ddc8a2dde3c55d", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer and Secretary", "year": 2020, "salary": 521000, "bonus": 0, "stockAwards": 1444290, "optionAwards": 718370, "nonEquityIncentiveCompensation": 234450, "otherCompensation": 2322, "total": 2920432}, {"id": "b7f4f7c6223d4e9988bcf6f53546ddb5", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2020, "salary": 445000, "bonus": 0, "stockAwards": 1085547, "optionAwards": 540456, "nonEquityIncentiveCompensation": 160200, "otherCompensation": 2322, "total": 2233525}, {"id": "302f36d620769ea669cfeeb8c5a66764", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2019, "salary": 643463, "bonus": 0, "stockAwards": 771400, "optionAwards": 1601697, "nonEquityIncentiveCompensation": 321732, "otherCompensation": 3564, "total": 3341856}, {"id": "523871a40e8e9bed80c0e097e5998958", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer and Secretary", "year": 2019, "salary": 495951, "bonus": 0, "stockAwards": 330600, "optionAwards": 557112, "nonEquityIncentiveCompensation": 198380, "otherCompensation": 2322, "total": 1584365}, {"id": "403ac3289f1aff6b0e81f161e0fbc7fa", "cik": "1340652", "ticker": "CCXI", "name": "Rajinder Singh, Ph.D.", "position": "Senior Vice President, Research", "year": 2019, "salary": 396977, "bonus": 0, "stockAwards": 110200, "optionAwards": 232128, "nonEquityIncentiveCompensation": 0, "otherCompensation": 1242, "total": 740547}, {"id": "e00a6542fb52d6f00909a59afc033f37", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2019, "salary": 426981, "bonus": 0, "stockAwards": 220400, "optionAwards": 487473, "nonEquityIncentiveCompensation": 134499, "otherCompensation": 2322, "total": 1271675}, {"id": "05339b999a1f2aa0731ea751b5db72e0", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2018, "salary": 616890, "bonus": 0, "stockAwards": 977400, "optionAwards": 1975654, "nonEquityIncentiveCompensation": 289959, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 2322, "total": 3862225}, {"id": "344d0be7e52ad1c207da2c207016f652", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2018, "salary": 409390, "bonus": 0, "stockAwards": 217200, "optionAwards": 476882, "nonEquityIncentiveCompensation": 134685, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 2322, "total": 1240479}, {"id": "0be7fc2353bebd32151167684ba1f8ab", "cik": "1340652", "ticker": "CCXI", "name": "William J. Fairey, Jr.", "position": "Former Executive Vice President, Chief Operating Officer", "year": 2018, "salary": 416667, "bonus": 0, "stockAwards": 0, "optionAwards": 2215533, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 983, "total": 2633183}, {"id": "663a60e94290cab0d3bc99395545795c", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer and Secretary", "year": 2018, "salary": 475570, "bonus": 0, "stockAwards": 325800, "optionAwards": 749386, "nonEquityIncentiveCompensation": 178790, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 2322, "total": 1731868}, {"id": "55ca66f721bf76a2b62985495dd2e2f9", "cik": "1340652", "ticker": "CCXI", "name": "Rajinder Singh, Ph.D.", "position": "Senior Vice President, Research", "year": 2018, "salary": 380620, "bonus": 0, "stockAwards": 162900, "optionAwards": 272504, "nonEquityIncentiveCompensation": 83481, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 1242, "total": 900747}, {"id": "db96db2467eb08c649c46933ef345beb", "cik": "1340652", "ticker": "CCXI", "name": "Jan L. Hillson, M.D., Ph.D.", "position": "Senior Vice President, Drug Development", "year": 2017, "salary": 380000, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 56525, "otherCompensation": 34358, "total": 470883}, {"id": "aeadd515280cbca90bfe1a2b03ab29c1", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer and Secretary", "year": 2017, "salary": 455955, "bonus": 0, "stockAwards": 264800, "optionAwards": 451000, "nonEquityIncentiveCompensation": 186030, "otherCompensation": 2322, "total": 1360107}, {"id": "83199e8dc27ec9bd22e8e3d8d5211e6c", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2017, "salary": 392508, "bonus": 0, "stockAwards": 198600, "optionAwards": 369000, "nonEquityIncentiveCompensation": 140125, "otherCompensation": 2322, "total": 1102555}, {"id": "ac222f15d4cb01c42b2bab23a501f895", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2017, "salary": 591451, "bonus": 0, "stockAwards": 662000, "optionAwards": 1148000, "nonEquityIncentiveCompensation": 251367, "otherCompensation": 2322, "total": 2655140}, {"id": "3c1ee1fd177e575c2cbd0de86b53ac94", "cik": "1340652", "ticker": "CCXI", "name": "Rajinder Singh, Ph.D.", "position": "Senior Vice President, Research", "year": 2017, "salary": 372600, "bonus": 0, "stockAwards": 198600, "optionAwards": 328000, "nonEquityIncentiveCompensation": 55424, "otherCompensation": 1242, "total": 955866}, {"id": "50a895d3cd325a6ece6d258c9f5e5731", "cik": "1340652", "ticker": "CCXI", "name": "Jan L. Hillson, M.D., Ph.D.", "position": "Senior Vice President, Drug Development", "year": 2016, "salary": 36051, "bonus": 40000, "stockAwards": 0, "optionAwards": 972480, "nonEquityIncentiveCompensation": 0, "otherCompensation": 2797, "total": 1051328}, {"id": "957c899e6ec135cf632455c2f3ead04d", "cik": "1340652", "ticker": "CCXI", "name": "Rajinder Singh, Ph.D.", "position": "Senior Vice President, Research", "year": 2016, "salary": 214154, "bonus": 0, "stockAwards": 0, "optionAwards": 223470, "nonEquityIncentiveCompensation": 84000, "otherCompensation": 495, "total": 522119}, {"id": "6894378a031269e78313e7f421163d1e", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2016, "salary": 571450, "bonus": 0, "stockAwards": 357000, "optionAwards": 635940, "nonEquityIncentiveCompensation": 285725, "otherCompensation": 1462, "total": 1851627}, {"id": "a9d55fc578a2d582add641e48c0af8ca", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Executive Vice President, Chief Financial and Administrative Officer", "year": 2016, "salary": 420523, "bonus": 0, "stockAwards": 837200, "optionAwards": 593422, "nonEquityIncentiveCompensation": 176214, "otherCompensation": 782, "total": 2028141}, {"id": "982008af9de9c3ee8caf0ae5a35b95c1", "cik": "1340652", "ticker": "CCXI", "name": "Petrus J. Bekker, M.D., Ph.D.", "position": "Chief Medical Officer", "year": 2016, "salary": 410405, "bonus": 0, "stockAwards": 142800, "optionAwards": 233178, "nonEquityIncentiveCompensation": 143642, "otherCompensation": 1462, "total": 931482}, {"id": "8952d26113d04c930130884059b9adb3", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2016, "salary": 379235, "bonus": 0, "stockAwards": 89250, "optionAwards": 137787, "nonEquityIncentiveCompensation": 132732, "otherCompensation": 1427, "total": 740431}, {"id": "23dc30c7b7c1b9ce4d2cc7edffc59628", "cik": "1340652", "ticker": "CCXI", "name": "Petrus J. Bekker, M.D., Ph.D.", "position": "Chief Medical Officer", "year": 2015, "salary": 410405, "bonus": 0, "stockAwards": 0, "optionAwards": 1179758, "nonEquityIncentiveCompensation": 114914, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 1290, "total": 1706367}, {"id": "5d3b2307aecbc34caa3e5ce520d079c4", "cik": "1340652", "ticker": "CCXI", "name": "Jan L. Hillson, M.D., Ph.D.", "position": "Senior Vice President, Drug Development", "year": 2015, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "60fe76e7ee89f97aadd7c729098652ce", "cik": "1340652", "ticker": "CCXI", "name": "Rajinder Singh, Ph.D.", "position": "Senior Vice President, Research", "year": 2015, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "a28ad8a847a74c7036a659ee8c852a3f", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2015, "salary": 571450, "bonus": 0, "stockAwards": 0, "optionAwards": 2117514, "nonEquityIncentiveCompensation": 228580, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 1290, "total": 2918834}, {"id": "5715b9f98a268794096c9a823c46f072", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2015, "salary": 415600, "bonus": 0, "stockAwards": 0, "optionAwards": 1033549, "nonEquityIncentiveCompensation": 116368, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 690, "total": 1566207}, {"id": "b97c2d025721184c665d2de7cf2dcb49", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer", "year": 2015, "salary": 379235, "bonus": 0, "stockAwards": 0, "optionAwards": 781464, "nonEquityIncentiveCompensation": 53093, "otherCompensation": 690, "total": 1214482}, {"id": "7d850840d130ccc8115237abffbaedc3", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2014, "salary": 550000, "bonus": 0, "stockAwards": 0, "optionAwards": 1837145, "nonEquityIncentiveCompensation": 247500, "otherCompensation": 1290, "total": 2635935}, {"id": "bebcaa9b37a8b4a55e1ce6eae287a5b1", "cik": "1340652", "ticker": "CCXI", "name": "Petrus J. Bekker, M.D., Ph.D.", "position": "Chief Medical Officer", "year": 2014, "salary": 384346, "bonus": 0, "stockAwards": 0, "optionAwards": 883690, "nonEquityIncentiveCompensation": 124425, "otherCompensation": 690, "total": 1393151}, {"id": "ec8d4ee3f0fdaff0043e0742e32cf32c", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2014, "salary": 400000, "bonus": 0, "stockAwards": 0, "optionAwards": 930200, "nonEquityIncentiveCompensation": 126000, "otherCompensation": 690, "total": 1456890}, {"id": "db216a56165dd846bfa73d26ec723844", "cik": "1340652", "ticker": "CCXI", "name": "Petrus J. Bekker, M.D., Ph.D.", "position": "Senior Vice President of Medical and Clinical Affairs", "year": 2013, "salary": 369382, "bonus": 0, "stockAwards": 0, "optionAwards": 676592, "nonEquityIncentiveCompensation": 106659, "otherCompensation": 690, "total": 1153323}, {"id": "c92f5b9bc6b7d040aebe3f7c9f1be4cb", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2013, "salary": 510000, "bonus": 0, "stockAwards": 0, "optionAwards": 1594824, "nonEquityIncentiveCompensation": 210375, "otherCompensation": 690, "total": 2315889}, {"id": "020eb3bbd9894060da90b3f701cef231", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2013, "salary": 372212, "bonus": 0, "stockAwards": 0, "optionAwards": 676592, "nonEquityIncentiveCompensation": 107476, "otherCompensation": 690, "total": 1156970}, {"id": "71e54e685251b43db4ccb791f3b255ab", "cik": "1340652", "ticker": "CCXI", "name": "Petrus J. Bekker, M.D., Ph.D.", "position": "Senior Vice President of Medical and Clinical Affairs", "year": 2012, "salary": 369382, "bonus": 0, "stockAwards": 0, "optionAwards": 1112903, "nonEquityIncentiveCompensation": 100841, "otherCompensation": 690, "total": 1583816}, {"id": "2ed19b23ea4d724de4b98b85b40edf4a", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2012, "salary": 482051, "bonus": 0, "stockAwards": 0, "optionAwards": 5748591, "nonEquityIncentiveCompensation": 219333, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 690, "total": 6450665}, {"id": "9c9da8263c60eb9193c6bd8a65aa4d62", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2012, "salary": 372212, "bonus": 0, "stockAwards": 0, "optionAwards": 1288087, "nonEquityIncentiveCompensation": 101614, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 690, "total": 1762604}, {"id": "bdf6e3a20eb8f2f83e8cf67f3d27b6b0", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer and Treasurer", "year": 2012, "salary": 354543, "bonus": 0, "stockAwards": 0, "optionAwards": 1322198, "nonEquityIncentiveCompensation": 96790, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 690, "total": 1774221}, {"id": "62d1d8f7e908138bf4f2fb9b5cb9cbf4", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2011, "salary": 465750, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 186300, "otherCompensation": 690, "total": 652740}, {"id": "bfe4f9ecd5fb42702409c4397cb43ca4", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2011, "salary": 359625, "bonus": 0, "stockAwards": 205802, "optionAwards": 0, "nonEquityIncentiveCompensation": 89906, "otherCompensation": 450, "total": 655783}, {"id": "14debb7704359c8a1e4486e0530ca474", "cik": "1340652", "ticker": "CCXI", "name": "Juan C. Jaen, Ph.D.", "position": "Senior Vice President, Drug Discovery and Chief Scientific Officer", "year": 2011, "salary": 362250, "bonus": 0, "stockAwards": 230232, "optionAwards": 0, "nonEquityIncentiveCompensation": 90563, "otherCompensation": 690, "total": 683735}, {"id": "730508b130f3ad12d34b679f0e059963", "cik": "1340652", "ticker": "CCXI", "name": "Markus J. Cappel, Ph.D.", "position": "Chief Business Officer and Treasurer", "year": 2011, "salary": 342554, "bonus": 0, "stockAwards": 0, "optionAwards": 226843, "nonEquityIncentiveCompensation": 85639, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 690, "total": 655726}, {"id": "5f4933e94d9e8b16b98463c4704c1ea2", "cik": "1340652", "ticker": "CCXI", "name": "Thomas J. Schall, Ph.D.", "position": "President and Chief Executive Officer", "year": 2010, "salary": 450000, "bonus": 0, "stockAwards": 1106281, "optionAwards": 0, "nonEquityIncentiveCompensation": 162000, "otherCompensation": 690, "total": 1718971}, {"id": "c1ddf4b44b9d93d31c773bb2fcacf2df", "cik": "1340652", "ticker": "CCXI", "name": "Juan C. Jaen, Ph.D.", "position": "Senior Vice President, Drug Discovery and Chief Scientific Officer", "year": 2010, "salary": 350000, "bonus": 0, "stockAwards": 418248, "optionAwards": 0, "nonEquityIncentiveCompensation": 78750, "otherCompensation": 690, "total": 847688}, {"id": "8c889e6e930dab42c724f127406628f5", "cik": "1340652", "ticker": "CCXI", "name": "Susan M. Kanaya", "position": "Senior Vice President, Finance and Chief Financial Officer", "year": 2010, "salary": 347464, "bonus": 4842, "stockAwards": 283994, "optionAwards": 0, "nonEquityIncentiveCompensation": 78179, "otherCompensation": 450, "total": 714929}]